Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,910 | 5,210 | 9,180 | 12,700 | 12,860 |
| Receivables | 250 | 310 | 360 | 250 | 2,060 |
| Other current assets | 130 | 140 | 220 | 330 | 270 |
| TOTAL | $4,290 | $5,660 | $9,760 | $13,280 | $15,190 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 200 | 8,120 | 8,120 | 8,120 |
| TOTAL | $N/A | $200 | $8,120 | $8,120 | $8,120 |
| Total Assets | $5,470 | $7,150 | $19,180 | $22,710 | $24,240 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 330 | 330 |
| Accounts payable and accrued liabilities | 1,200 | 1,730 | 2,140 | 2,840 | 2,300 |
| Accrued Expenses | 1,130 | 1,020 | 1,130 | 1,130 | 1,070 |
| Other current liabilities | 1,770 | 1,220 | 1,860 | 1,670 | 80 |
| TOTAL | $4,100 | $3,980 | $5,140 | $5,980 | $3,800 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,760 | 6,930 | 7,090 | 7,250 | 7,410 |
| TOTAL | $6,760 | $6,932 | $7,094 | $7,256 | $7,417 |
| Total Liabilities | $10,870 | $10,920 | $12,240 | $13,240 | $11,220 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3 | 3 | 3 | 3 | 3 |
| Common Shares | 200 | 200 | 200 | 200 | 190 |
| Retained earnings | -322,650 | -320,870 | -310,020 | -307,360 | -303,560 |
| TOTAL | $-5,400 | $-3,770 | $6,940 | $9,460 | $13,020 |
| Total Liabilities And Equity | $5,470 | $7,150 | $19,180 | $22,700 | $24,240 |